[
    [
        {
            "time": "",
            "original_text": "高瓴为何看中药明康德？张磊：传统行业公司需要用科技重组产业链",
            "features": {
                "keywords": [
                    "高瓴",
                    "中药明康德",
                    "张磊",
                    "科技重组",
                    "产业链"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "高瓴为何看中药明康德？张磊：传统行业公司需要用科技重组产业链",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]